358 related articles for article (PubMed ID: 27036048)
1. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
[TBL] [Abstract][Full Text] [Related]
2. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.
Lin M; Guo LM; Liu H; Du J; Yang J; Zhang LJ; Zhang B
Histol Histopathol; 2010 Oct; 25(10):1269-75. PubMed ID: 20712011
[TBL] [Abstract][Full Text] [Related]
4. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
6. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
7. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
8. GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells.
Huang D; Wang Y; Xu L; Chen L; Cheng M; Shi W; Xiong H; Zalli D; Luo S
J Exp Clin Cancer Res; 2018 Oct; 37(1):247. PubMed ID: 30305138
[TBL] [Abstract][Full Text] [Related]
9. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
11. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
Liu Y; Song J; Liu Y; Zhou Z; Wang X
J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
[TBL] [Abstract][Full Text] [Related]
12. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
Huang S; Li J; Tam NL; Sun C; Hou Y; Hughes B; Wang Z; Zhou Q; He X; Wu L
Mol Carcinog; 2019 Apr; 58(4):603-615. PubMed ID: 30556610
[TBL] [Abstract][Full Text] [Related]
13. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
Zhou ZQ; Zhao JJ; Chen CL; Liu Y; Zeng JX; Wu ZR; Tang Y; Zhu Q; Weng DS; Xia JC
Mol Carcinog; 2019 Jan; 58(1):76-87. PubMed ID: 30182378
[TBL] [Abstract][Full Text] [Related]
14. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
17. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
18. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
19. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
